Skip to main content
Premium Trial:

Request an Annual Quote

Pause Recommended

Two US federal agencies have called for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine so reports of a rare blood clot side effect may be investigated, the Wall Street Journal reports.

"We are recommending a pause in the use of this vaccine out of an abundance of caution," the Food and Drug Administration and the Centers for Disease Control and Prevention say in a joint statement. J&J's SARS-CoV-2 vaccine is a one-dose regimen that received Emergency Use Authorization from the FDA in March and, according to the FDA and CDC, about 6.8 million doses of the vaccine have been administered.

Six women developed cerebral venous sinus thrombosis with low blood platelet levels between six and 13 days after they received the J&J vaccine. The Journal reports that an outside panel is to review the data Wednesday for the CDC, while the FDA will perform its own investigation.

The Verge adds that the European Medicines Agency similarly announced it would be reviewing the J&J vaccine following reports of four cases of blood clots there. The EMA recently reviewed AstraZeneca's SARS-CoV-2 vaccine, which has also been tied to reports of rare blood clots, and the Journal notes that some countries have restricted the administration of the AstraZeneca vaccine to certain age groups.

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.